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Of 38 adolescents hospitalized with major depression, 47% of those receiving psychosocial treatment 
alone responded. Of the non-responders then treated with combined tricyclic antidepressants and 
psychosocial treatment, 92% responded. The melancholic subtype and dexamethasone suppression test 
non-suppression were associated with failure to respond to psychosocial treatment alone. Implications for 
controlled studies are discussed. 
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Introduction 
No controlled studies have demonstrated ef- 
ficacy of any modality for the treatment of major 
depression (MD) in adolescents. The only con- 
trolled study of tricyclic antidepressants (TCA) 
reported no difference between amitriptyline and 
placebo, but was limited by a small sample, lack 
of an initial drug-free phase, and ambiguous 
criteria for diagnosis and improvement (Kramer 
and Feiguine, 1983), and an uncontrolled trial of 
imipramine in outpatients reported improvement 
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of only 44% (Ryan et al., 1986). Similarly, no 
controlled studies of psychosocial modalities, such 
as cognitive and interpersonal therapies, have been 
reported in adolescents. Observed similarities be- 
tween juvenile and adult forms of affective dis- 
order in phenomenology (Kandell and Davies, 
1986) incidence of dexamethasone suppression 
test (DST) non-suppression (Robbins et al., 1983; 
Preskorn et al., 1987) and family history (Kovacs 
and Paulauskas, 1984) however, suggest that 
treatment response may also follow patterns seen 
in adults. 
The identification of clinical subtypes may be 
important in the design and evaluation of clinical 
trials, for associations between subtypes and re- 
sponse to psychosocial or somatic treatment have 
been seen in adults. The failure to make such 
0165-0327/89/$03.50 0 1989 Elsevier Science Publishers B.V. (Biomedical Division) 
100 
distinctions in the design of a study could lead to 
the test of a treatment in a population including 
subgroups in which the response rate could be 
expected to be low with the consequent minimiza- 
tion of significant treatment effects. 
Certain subtype distinctions have appeared to 
be associated with treatment response in adult 
populations. The endogenous or melancholic sub- 
type is associated with greater response to tricyclic 
antidepressants than to psychosocial therapies 
(Prusoff et al., 1980; Nelson et al., 1984). Delu- 
sional patients (Spiker et al., 1985), bipolar pa- 
tients in an episode of depression (Himmelhoch et 
al., 1972) and ‘atypical’ depressives (Klein et al., 
1980) are other phenomenologic subtypes for 
which evidence exists in adult populations suggest- 
ing different treatment needs. Other subgroups 
may also have particular patterns of treatment 
responsiveness, such as those in whom comorbid- 
ity exists with panic disorder or dysthymia. It 
appears plausible that biological as well as clinical 
indicators might exist of the need for and response 
to somatic treatments, but despite considerable 
effort, such profiles remain elusive. DST non-sup- 
pression has been reported to be associated with 
failure to respond to placebo in two studies of 
adults (Peselow et al., 1986; Brown et al., 1987) 
and in one of prepubertal children (Preskorn et 
al., 1987). A study of cognitive therapy in adult 
outpatients reported an association of non-sup- 
pression with poor response (Rush, 1982). 
This paper reports naturalistic, uncontrolled 
clinical experience of the treatment of adolescents 
hospitalized with MD. It describes the association 
of response to psychosocial treatment alone and 
combined with tricyclic antidepressants with the 
melancholic and non-melancholic subtypes and 
with DST non-suppression. 
Method 
As part of a study of the sensitivity and 
specificity of the DST in adolescence, psychiatric 
inpatients were interviewed using the Schedule for 
Affective Disorders and Schizophrenia (SADS) by 
two child psychiatrists, and a DSM-III diagnosis 
was assigned. The reliability and validity of 
criteria-based diagnoses in adolescents, based on 
semi-structured interviews, has been described 
elsewhere (Strober et al., 1981; Robbins et al., 
1982). It should be noted that all those meeting 
criteria for MD were significantly incapacitated 
by their symptoms, and generally exceeded by 
weeks to months the requirement for 2-week dura- 
tion. No patients had significant medical illness. 
Mean age was 15.6 years; age range was 13317. 
All were free of psychotropic medications at least 
2 weeks prior to the DST. Consenting patients 
were given a 1 mg DST with blood samples at 
11:OO p.m. on day 1; and at 8:00 a.m., 4:00 p.m., 
and 11:OO p.m. on day 2. Cortisol assays were 
done by competitive protein binding (Ritchie et 
al., 1985). Exclusion criteria for the DST and 
results of the DST study have been reported 
elsewhere (Robbins et al., 1983). DST results were 
kept blind until diagnoses were assigned. Since the 
SADS and DST were part of a study of diagnosis 
and DST, not including formal study of treatment 
response, DST results were known to the attend- 
ing psychiatrist 2 weeks after admission. Neither 
subsequent treatment decisions nor assessment of 
response were blind to diagnostic subtype or DST 
results. This report describes the uncontrolled 
treatment experience with depressed adolescents 
included in the study of the DST and initial 
diagnosis. 
Adolescents meeting criteria for MD received 
intensive psychosocial treatment alone for at least 
6 weeks, consisting of psychodynamically oriented 
interpersonal individual psychotherapy three times 
per week, family therapy weekly, group therapy 
twice weekly, and an active cognitive-behavioral 
therapeutic milieu. Psychotherapy emphasized 
current relationship difficulties, particularly be- 
tween the adolescent and his or her immediate 
family and peers. Specific traumatic events or 
relationships were addressed, but early experience, 
intrapsychic material, and regressive transferences 
were not emphasized. While a specific therapy 
manual was not used, the approach was similar to 
that described as interpersonal psychotherapy 
(Klerman et al., 1984). The activities of the inpa- 
tient program attempted to reflect common expe- 
riences of an adolescent’s daily life ~ e.g., school, 
chores, social interactions, dealing with authority 
figures - with regulation by staff to create expe- 
riences of oneself as effective and worthwhile and 
of the world and future as positive. The milieu, 
101 
then, integrated elements of interpersonal and 
cognitive-behavioral approaches. Though impure 
from a research perspective, this approach to psy- 
chosocial treatment is not unusual in the treat- 
ment of adolescents, and may add to the gener- 
alizability of these observations. A trial of TCA 
was considered for those who failed to respond as 
judged by their attending psychiatrist as having 
persisting depression or anhedonia equivalent to 
SADS item ratings of 3 or more. Active psychoso- 
cial treatment was continued during TCA treat- 
ment. Since the relationship of response to dose or 
plasma level is not established in adolescents, 
dosage was selected to achieve blood levels re- 
ported as efficacious in adults within 2 weeks or 
less, e.g., for desipramine, 150-225 ng/ml imip- 
ramine plus desipramine. Patients were considered 
to have had an adequate trial if they remained at 
such levels for 4 weeks. Improvement was based 
on the judgement by the attending physician 
(M.V.C. or D.R.R.) equivalent to a SADS item 
rating of 1 (‘not at all’) or 2 (‘slight’) for the 
depression and anhedonia items. 
Results 
Of 81 patients admitted who consented to a 
SADS interview and a DST, 38 met DSM-III 
criteria for MD. Data on the association of the 
DST and diagnosis have been previously reported 
(Robbins et al., 1983). Of the 38, 23 received 
psychosocial treatment alone, only 15 received 
TCA with continued psychosocial treatment. 
Eighteen of the 38 patients (47%) responded to 
psychosocial treatment alone. Of 19 non-melan- 
cholic (Non-Mel) patients, 13 responded without 
medication (68%), while of 19 melancholic (Mel) 
patients only five responded without medication 
(26%) (x2, Yates correction = 5.17, P -c 0.05, df = 
1) (Table 1). Eighteen of 31 (58%) DST suppres- 
sors and no non-suppressors improved with inten- 
sive psychosocial interventions without medi- 
cations (x2, Yates correction = 4.56, P < 0.05, df 
= 1) (Table 2). All patients who responded to 
psychosocial treatment alone were DST suppres- 
sors. Five suppressors failed to respond to psy- 
chosocial treatment alone, but did not receive 
TCA because of refusal by the patient or family. 
All seven non-suppressors failed to respond to 
TABLE 1 
MELANCHOLIC SUBTYPE AND RESPONSE TO PSY- 
CHOSOCIAL TREATMENT ALONE 
Melancholic Non-melancholic Total 
Responders 5 13 18 
Non-responders 14 6 20 
Chi square, Yates correction = 5.17, P i 0.05, df = 1. 
psychosocial treatment alone and went on to TCA 
trials. 
Fifteen patients who failed to respond to psy- 
chosocial treatment alone were given trials of TCA: 
10 with desipramine alone, two with imipramine, 
one with amitriptyline alone, one with nortripty- 
line, and one first with desipramine and then with 
amitriptyline. Of these, three had trials inter- 
rupted by adverse reactions - two because of 
hypomania, and one because of persistent ortho- 
static hypotension on desipramine and acute 
urinary retention on amitriptyline. Of the 12 com- 
pleting trials, 11 (92%) has positive responses to 
TCA alone. One developed hypomania on de- 
sipramine, had a recurrence of depression on 
lithium, but did well on desipramine and lithium. 
All five Non-Mel patients responded to TCA (Ta- 
ble 3). Six of seven Mel patients (86%) responded 
to TCA alone; one responded to desipramine and 
lithium. All DST suppressors and five of six non- 
suppressors responded to tricyclic alone with one 
non-suppressor responding to desipramine and 
lithium (Table 4). 
Of those who received adequate trials of TCA 
or TCA and lithium, essentially all improved 
markedly with respect to the core symptoms of 
major depression, depressed mood and anhedonia, 
so medication response was not associated with 
TABLE 2 
DEXAMETHASONE SUPPRESSION AND RESPONSE TO 
PSYCHOSOCIAL TREATMENT ALONE 
DST non- DST 
suppression suppression 
Total 
Responders 0 18 18 
Non-responders 7 13 20 
Chi square, Yates correction = 4.56, P c 0.05, df = 1. 
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TABLE 3 Discussion 
NON-RESPONDERS TO PSYCHOSOCIAL TREATMENT 
ALONE: MELANCHOLIC SUBTYPE AND RESPONSE TO 
MEDICATION PLUS PSYCHOSOCIAL TREATMENT 
The observation that approximately half of a 
sample of adolescents hospitalized for major de- 
pression improved without medication while others 
required somatic treatment suggests the heteroge- 
neous nature of the DSM-III diagnostic category 
of major depression. Despite having symptoms 
severe enough to require hospitalization, a large 
subgroup experienced improvement after the be- 
ginning of family and individual psychotherapy 
and a move from home to the inpatient milieu, 
while others remained depressed until medication 
was added. Such a high apparent response to 
psychosocial treatment of major depression, par- 
ticularly in the Non-Mel and DST-suppressing 
subgroups, deserves further study. We cannot 
know how many remitted spontaneously, unre- 
lated to treatment, although most had been symp- 
tomatic for weeks or months and improved within 
the first 4 weeks of hospitalization. This is con- 
sistent with the finding of a high (68%) placebo 
response rate in a study of prepubertal depression 
(Puig-Antich et al., 1987). The only controlled 
study of a TCA in adolescents (Kramer and 
Feiguine, 1983) began medication after a 2-day 
‘adjustment period’, and then found high rates of 
improvement in both placebo- and amitriptyline- 
treated groups with no difference between groups. 
Conceivably, both groups included many patients 
who would have responded without medication. 
Melan- Non-melan- Total 
cholic cholic 
Responders to TCA alone 6 5 11 
Responders to TCA/Li 1 0 1 
Non-responders 0 0 0 
Inadequate trials 3 0 3 
TCA, tricyclic antidepressant; TCA/Li, tricyclic antide- 
pressant plus lithium carbonate. 
DST results or diagnostic subtype. In some of the 
adolescents, behavioral symptoms, e.g., running 
away, or cognitive symptoms such as poor self- 
esteem or pessimism persisted. This is consistent 
with the differential effect reported in adults of 
tricyclic antidepressants on ‘ vegetative’ symp- 
toms, with later, perhaps independent improve- 
ment in cognitive constructs and social function 
(Weissman et al., 1974; DiMascio et al., 1979; 
Rush, 1982; Simons et al., 1984). The clinical 
impression was that in a minority of these patients 
improvement in depression was associated with a 
global improvement in all symptoms, while in the 
majority such symptoms as conduct disorder, pro- 
vocative behavior within the family, or dis- 
turbance of self-perception persisted but became 
more accessible to psychosocial approaches. 
The distinction of Mel and Non-Mel clinical 
subtypes appears to be meaningful. Of the Non- 
TABLE 4 
NON-RESPONDERS TO PSYCHOSOCIAL TREATMENT ALONE: DEXAMETHASONE SUPPRESSION AND RESPONSE 
TO MEDICATION PLUS PSYCHOSOCIAL TREATMENT 
DST non-suppression DST suppression 
Responders to TCA alone 6 5 
Responders to TCA/Li 1 0 
Non-responders 0 0 
Inadequate trials 3 0 







Mel group, 68% were successfully treated without 
medication, while of the Mel patients treated 
without medication only 26% appeared to im- 
prove. Of those non-responders to psychosocial 
treatment who were given medications, both sub- 
types improved equally. 
DST non-suppression appeared to be associ- 
ated with a failure to respond to psychosocial 
treatment alone, or a need for somatic treatment. 
Despite the program’s approach of giving patients 
weeks to months to respond to psychosocial inter- 
ventions, it appears noteworthy that all those with 
DST non-suppression eventually were considered 
to require medication. 
These observations are limited by several fac- 
tors. Treatment assignment and judgements of 
efficacy were not blind to clinical subtype or DST 
results, and may have been biased. Specific proto- 
cols for tricyclic administration and psychosocial 
treatment were not used. Judgements of efficacy 
focused on depressed mood and anhedonia and 
did not include other symptoms known to respond 
to treatment. Placebo control groups were not 
used. Unfortunately, systematic data on ad- 
ditional variables of possible importance, such as 
family psychiatric history or comorbidity with 
substance abuse, conduct disorder, or personality 
disorder, are not available. 
This clinical report suggests methodological is- 
sues for prospective, controlled studies. A medica- 
tion-free interval after hospitalization of at least 2 
weeks appears important to identify patients who 
improve without medication. DST or other bio- 
logical study results should remain blind through- 
out the trials. Psychosocial interventions need to 
be either controlled or at least specified (e.g., 
cognitive, interpersonal). Diagnoses and response 
need to be defined by specific criteria. The 
Mel-Non-Mel distinction appears important, and 
an analysis of specific symptoms within the Mel 
constellations - e.g., psychomotor retardation, di- 
urnal variation - may yield a more specific profile 
of the depressed adolescent who requires and re- 
sponds to TCA. The degree and timing of the 
responses of specific symptoms to both psychoso- 
cial and pharmacological treatment should be de- 
fined. The DST appears t_o deserve study as an 
indicator of the need for somatic treatment and 
deserves further study, as does the observation 
that many patients continue to have serious be- 
havioral, family, and cognitive disturbances fol- 
lowing the resolution of their depressive symp- 
toms. Controlled, more specific observations may 
help us to prescribe both psychosocial and somatic 
therapies more precisely. Beyond both clinical ap- 
plications and the implications for the adolescent 
population, the relationships among clinical char- 
acteristics, biological correlates, and treatment re- 
sponse may allow us to dissect the heterogeneous 
phenomenon of major depression into subtypes 
more meaningfully related to underlying mecha- 
nisms. 
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